✦ LIBER ✦

Cholangiocarcinoma in patients with primary sclerosing cholangitis: A multicenter case-control study

✍ Scribed by Naga Chalasani; Arthur Baluyut; Ayaaz Ismail; Atif Zaman; Gagan Sood; Reem Ghalib; T. M. McCashland; K. Rajender Reddy; Xaralambos Zervos; Mann A. Anbari; Helena Hoen

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 100 KB
Volume: 31
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.510310103

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Advances in the diagnosis of cholangioca

Advances in the diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis

✍ Laura E. Moreno Luna; Gregory J. Gores 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB

Primary sclerosing cholangitis (PSC) is an idiopathic chronic cholestatic liver disease characterized by inflammatory destruction of the biliary tree. It slowly progresses, resulting in biliary fibrosis and obliteration leading to end-stage liver disease. The most feared complication of PSC is the d

Primary sclerosing cholangitis and color

Primary sclerosing cholangitis and colorectal carcinoma in patients with chronic ulcerative colitis : A case-control study

✍ Kofi W. Nuako; David A. Ahlquist; William J. Sandborn; Douglas W. Mahoney; Diane 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB 👁 2 views

## Background: Controversy persists regarding primary sclerosing cholangitis (psc) as a risk factor for colorectal carcinoma in patients with chronic ulcerative colitis. small sample size and differing endpoints have contributed to variation among reported studies. this large case-control study was

Cholangiocarcinoma in primary sclerosing

Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms

✍ Espen Melum; Tom H. Karlsen; Erik Schrumpf; Annika Bergquist; Erik Thorsby; Kirs 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 232 KB 👁 1 views

Risk factors and clinical presentation o

Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: A case-control study

✍ Annika Bergquist; Hans Glaumann; Bo Persson; Ulrika Broomé 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

The reason why 10% to 20% of all patients with primary sclerosing cholangitis (PSC) develop cholangiocarcinoma (CC) remains unknown. The aim of this study was to compare the clinical and biochemical presentation in PSC patients with and without hepatobiliary malignancy and to look for risk factors f

CA19-9 Does Not Predict cholangiocarcino

CA19-9 Does Not Predict cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis Undergoing Liver Transplantion

✍ Fisher, Adrian ;Theise, Neil D. ;Min, Albert ;Mor, Eytan ;Emre, Sukru ;Pearl, Ad 📂 Article 📅 1995 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 424 KB

The results of liver transplantation in patients with cholangiocarcinoma have been poor. It has been suggested that elevated serum CA19-9 levels predict cholangiocarcinoma in patients with primary sclerosing cholangitis. We analyzed the predictive value of CAl9-9 antigen as a marker of cholangiocarc

Predicting cholangiocarcinoma in patient

Predicting cholangiocarcinoma in patients with primary sclerosing cholangitis: An analysis of the serological marker CA 19-9

✍ Steven A. Rogers; Daniel K. Podolsky 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 395 KB